High-Quality Brain and Bone Marrow Nuclei Preparation for Single Nuclei Multiome Assays
December 22nd, 2023
3.7K views
The success of single-cell/single-nuclei transcriptomics and multi-omics largely depends on the quality of cells/nuclei. Therefore, isolating cells/nuclei from tissue and their purification must be highly standardized. This protocol describes the preparation of nuclei from the brain and bone marrow for downstream single-nuclei multiome assay.
Overview
This study focuses on the optimization of nuclei isolation from brain and bone marrow tissues for downstream single-nuclei multiome assays. The importance of high-quality nuclei extraction is highlighted due to its impact on single-cell transcriptomics and multi-omics analyses.
Key Study Components
Research Area
- Single-cell transcriptomics
- Multi-omics
- Nuclei isolation techniques
Background
- The success of transcriptomics relies on the purity and quality of isolated cells/nuclei.
- Recent advancements in flow cytometry and image-based technologies enhance cell sorting capabilities.
- Special consideration is needed for fragile or rare cell populations, necessitating optimized protocols.
Methods Used
- Modified nuclei preparation protocol for brain and bone marrow tissues
- Mouse model system
- Techniques include flow cytometry and automated cell counting
Main Results
- Improved nuclei recovery rates with minimized stress during preparation.
- Purity of brain nuclei increased from 36% to nearly 100% after sorting.
- Established a reliable workflow to prepare nuclei for high-quality sequencing data.
Conclusions
- This study demonstrates an effective protocol for isolating high-purity nuclei from specific tissues.
- The findings have significant implications for enhancing single-cell multiomic analyses in health and disease research.
Frequently Asked Questions
What is the main goal of this study?
To optimize the protocol for nuclei isolation from brain and bone marrow tissues for improved single-nuclei multiome assays.
Why is nuclei purity important?
High nuclei purity is essential for accurate transcriptional profiling and reliable data in single-cell analyses.
What methods are used to isolate nuclei?
The study utilizes a modified nuclei preparation protocol that includes lysis buffer and flow cytometry.
What improvements were observed in nuclei recovery?
Nuclei recovery improved significantly, with brain nuclei purity rising from 36% to nearly 100% post-sorting.
Which tissues are focused on in this research?
The research specifically focuses on mouse brain and bone marrow tissues.
How does the new protocol affect sequencing data quality?
The optimized protocol aims to yield high-quality sequencing data by ensuring high viability and purity of isolated nuclei.
What are the implications of this study?
This study could significantly enhance research methodologies in the fields of genomics and single-cell biology.
Executive Industry Relevance
High-quality nuclei preparation from brain and bone marrow is foundational for robust single-nuclei multiome assays, directly impacting the reliability of transcriptomic and epigenetic profiling in early discovery. Standardized protocols for nuclei isolation enable consistent data generation, supporting predictive confidence and mechanistic de-risking in complex tissue studies. This capability is critical for advancing disease-relevant models and accelerating portfolio decisions in neurobiology and hematology research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cell-type-specific transcriptional and epigenetic states in complex tissues.
- Supports functional target validation by providing high-integrity nuclei for multiomic readouts.
- Facilitates mechanistic de-risking through reproducible sample preparation and data quality.
Screening & Assay Development
- Delivers validated nuclei suspensions optimized for downstream 10X Genomics multiome workflows.
- Improves assay reproducibility and standardization by minimizing sample variability.
- Enables scalable preparation of nuclei libraries for high-throughput compound or perturbation screening.
Translational & Preclinical Research
- Aligns with disease-relevant tissue models for translational biomarker discovery.
- Ensures continuity from discovery through preclinical validation by maintaining nuclei quality across experiments.
- Reduces risk of technical artifacts that could confound preclinical data interpretation.
Pipeline & Workflow Integration
This nuclei preparation protocol integrates at the interface of tissue processing and single-nuclei multiome sequencing, supporting workflows from early discovery through preclinical research.
- Discovery Biology: Provides high-quality nuclei for hypothesis testing and pathway analysis in brain and bone marrow tissues.
- Screening: Ensures assay readiness and reproducibility for multiomic profiling platforms.
- Analytics: Delivers quantitative nuclei quality metrics to inform downstream data analysis and condition comparison.
- Translational Research: Supports biomarker alignment and disease model fidelity by preserving nuclei integrity.
- Enterprise Reuse: Establishes a standardized, reusable protocol adaptable to diverse tissue types and studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in multiomic studies.
- Operational Value: Enhances standardization, reproducibility, and scalability of nuclei isolation workflows.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by ensuring reliable data inputs.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of neurobiology and hematology programs.
Implementation Considerations
- Requires expertise in tissue dissociation, nuclei isolation, and quality control assessment.
- Needs access to flow cytometry, automated cell counting, and sequencing infrastructure.
- Demands cross-team standardization to ensure reproducibility across studies and sites.
- May require protocol adaptation for different tissue types or species.
- Dependent on maintaining nuclei viability and integrity throughout processing steps.
Biopharma FAQs
Why does null hypothesis testing matter for nuclei quality control?
Null hypothesis testing in nuclei quality control enables teams to statistically confirm that observed differences in nuclei integrity or purity are not due to random variation, supporting confident target validation and mechanistic interpretation.
How does independent variable isolation fit nuclei preparation workflows?
Isolating variables such as tissue type or dissociation conditions during nuclei preparation allows for controlled assessment of protocol impact, ensuring that downstream multiome data reflect true biological differences rather than technical artifacts.
What do quantitative dependent variable measurements enable in nuclei QC?
Quantitative measurements of nuclei viability, integrity, and purity provide objective criteria for sample acceptance, enabling reliable comparison across experiments and supporting robust multiomic data generation.
Why are replication requirements critical for cross-functional nuclei workflows?
Replication ensures that nuclei isolation protocols yield consistent results across operators and sites, facilitating cross-functional collaboration and reproducibility in multi-site discovery and preclinical programs.
What statistical analysis capabilities are required before nuclei protocol implementation?
Teams must be able to perform statistical analyses on nuclei quality metrics, such as purity and recovery rates, to validate protocol performance and ensure readiness for integration into high-throughput multiome pipelines.
